5 Best Long-Term Stocks To Buy According To Warren Buffett

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 88

Johnson & Johnson (NYSE:JNJ) is an American multinational healthcare company that operates in various sectors of the healthcare industry. As of October 26, Johnson & Johnson (NYSE:JNJ) provides a quarterly dividend of $1.19 per share, with a dividend yield of 3.14%. The company has a commendable track record of dividend growth, having increased its dividend consistently for more than 62 years.

Warren Buffett initiated his position in Johnson & Johnson (NYSE:JNJ) in 2010 by acquiring 42.62 million shares. Over the decade from 2012 to 2022, the stock exhibited an impressive gain of 186%, which translated into significant returns for the billionaire investor. As of the second quarter of 2023, Berkshire Hathaway held 327,100 shares in Johnson & Johnson (NYSE:JNJ), with a total value exceeding $54.14 million.

In the second quarter of 2023, the number of hedge funds holding positions in Johnson & Johnson (NYSE:JNJ) increased to 88, up from 86 in the previous quarter. The total value of these hedge funds’ combined stakes in Johnson & Johnson surpasses $4.1 billion. Bridgewater Associates, led by Ray Dalio, is the primary hedge fund investor in Johnson & Johnson (NYSE: JNJ), holding a significant stake valued at approximately $526.58 million.

Follow Johnson & Johnson (NYSE:JNJ)